Amundi Asset Management US’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$385M Buy
13,087,232
+1,287,355
+11% +$39.6M 0.29% 74
2020
Q4
$362M Buy
11,799,877
+3,653,654
+45% +$111M 0.31% 76
2020
Q3
$228M Sell
8,146,223
-1,613,372
-17% -$40.9M 0.24% 89
2020
Q2
$209M Sell
9,759,595
-6,556,912
-40% -$145M 0.25% 89
2020
Q1
$365M Buy
16,316,507
+796
+0% +$21.8K 0.64% 31
2019
Q4
$480M Buy
16,315,711
+5,364,089
+49% +$146M 0.56% 36
2019
Q3
$291M Sell
10,951,622
-405,052
-4% -$12.2M 0.43% 46
2019
Q2
$384M Buy
11,356,674
+478,550
+4% +$15.5M 0.31% 85
2019
Q1
$349M Buy
10,878,124
+5,111,146
+89% +$157M 0.49% 47
2018
Q4
$182M Buy
5,766,978
+5,761,978
+115,240% +$189M 0.17% 98
2018
Q3
$174K Buy
+5,000
New +$176K ﹤0.01% 1467

Other funds holding ELAN

Amundi Asset Management US's ELAN Position: Q1 2021 in Review

Amundi Asset Management US increased its Elanco Animal Health (ELAN) stake by 11% in Q1 2021, buying an estimated $39.6M and bringing the position to 13,087,232 shares worth $385M. The position accounts for 0.29% of the portfolio, ranked #74.

Amundi Asset Management US first reported a position in ELAN in Q3 2018 and has held it in 11 quarters since. The position peaked at $480M in Q4 2019. 450 funds tracked by Wall St. Rank hold ELAN as of Q1 2021.

  • Amundi Asset Management US held 13,087,232 shares of Elanco Animal Health worth $385M as of Q1 2021.
  • Amundi Asset Management US bought 1,287,355 Elanco Animal Health shares in Q1 2021, an estimated $39.6M.
  • Elanco Animal Health made up 0.29% of Amundi Asset Management US's portfolio in Q1 2021, its #74 holding.
  • Amundi Asset Management US first reported a position in Elanco Animal Health in Q3 2018 and has held it in 11 quarters since.
  • Amundi Asset Management US's Elanco Animal Health position peaked at $480M in Q4 2019.
  • 450 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.